Patent details

Basic Information

Publication number:

EP1664316

PCT Application Number:

PCT/CA/2004/001677

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP047618384

PCT Publication Number:

WO/2005/026372

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

POLYETHYLENEGLYCOL-MODIFIED LIPID COMPOUNDS AND USES THEREOF

French Title of Invention:

COMPOSES LIPIDIQUES MODIFIES AVEC DU POLYETHYLENEGLYCOL ET UTILISATIONS DE CES COMPOSES

German Title of Invention:

POLYETHYLENGLYCOL-MODIFIZIERTE LIPIDVERBINDUNGEN UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

15/09/2004

Grant date:

29/08/2012

EP Publication Date:

29/08/2012

PCT Publication Date:

24/03/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/06/2006

EP B1 Publication Date:

29/08/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/09/2012

Expiration date:

15/09/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/09/2004

 

 

Name:

Protiva Biotherapeutics Inc.

Address:

100-8900 Glenlyon Parkway, Burnaby, British Columbia V5J 5J8, Canada (CA)

Inventor

1

Name:

HEYES James

Address:

Canada (CA)

2

Name:

AMBEGIA Ellen Grace

Address:

Canada (CA)

3

Name:

MACLACHLAN Ian

Address:

Canada (CA)

Priority

Priority Number:

503239 P

Priority Date:

15/09/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 15/88;

Filing date	Document type	Number of pages